NCT06977594 2025-06-24Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic CancerSeoul National University HospitalPhase NA Not yet recruiting1,000 enrolled
NCT06363708 2024-04-12Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial CancerZhongnan HospitalPhase NA Not yet recruiting20 enrolled